# OnCo record cho-byoung-chul (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/cho-byoung-chul/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "cho-byoung-chul" ;
  schema:name "Byoung Chul Cho"@en ;
  schema:description "Co-led MARIPOSA, the trial where amivantamab plus lazertinib beat osimertinib, and a leading figure in Asian lung cancer drug development."@en ;
  schema:url <https://onco.cc/people/cho-byoung-chul/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://sev.severance.healthcare>, <https://pubmed.ncbi.nlm.nih.gov/?term=Cho%20BC%5BAuthor%5D%20Yonsei%20lung%20cancer> ;
  schema:jobTitle "Professor, Division of Medical Oncology; Director, Yonsei Lung Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/met/> ;
  onco:drugs <https://onco.cc/drugs/amivantamab/>, <https://onco.cc/drugs/lazertinib/> ;
  onco:institutions <https://onco.cc/institutions/severance/> ;
  onco:trials <https://onco.cc/trials/mariposa/> ;
  schema:affiliation <https://onco.cc/institutions/severance/> .